Poulin Y - Search Results

1

Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.

Reich K, Papp KA, Matheson RT, Tu JH, Bissonnette R, Bourcier M, Gratton D, Kunynetz RA, Poulin Y, Rosoph LA, Stingl G, Bauer WM, Salter JM, Falk TM, Blödorn-Schlicht NA, Hueber W, Sommer U, Schumacher MM, Peters T, Kriehuber E, Lee DM, Wieczorek GA, Kolbinger F, Bleul CC. Reich K, et al. Among authors: poulin y. Exp Dermatol. 2015 Jul;24(7):529-35. doi: 10.1111/exd.12710. Epub 2015 May 8. Exp Dermatol. 2015. PMID: 25828362 Free PMC article. Clinical Trial.

2

Olmsted syndrome-palmoplantar and periorificial keratodermas: association with malignant melanoma.

Dessureault J, Poulin Y, Bourcier M, Gagne E. Dessureault J, et al. Among authors: poulin y. J Cutan Med Surg. 2003 May-Jun;7(3):236-42. doi: 10.1007/s10227-002-0107-4. J Cutan Med Surg. 2003. PMID: 12704531 Review.

3

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

4

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.

Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; ISA247 Psoriasis Study Group. Bissonnette R, et al. Among authors: poulin y. J Am Acad Dermatol. 2006 Mar;54(3):472-8. doi: 10.1016/j.jaad.2005.10.061. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16488299 Clinical Trial.

5

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: poulin y. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

6

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: poulin y. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

7

A favourable benefit/risk ratio with efalizumab: a review of the clinical evidence.

Poulin Y, Papp KA, Carey W, Gulliver W, Gupta AK. Poulin Y, et al. J Cutan Med Surg. 2006;9 Suppl 1:10-7. doi: 10.1007/s10227-006-0102-2. J Cutan Med Surg. 2006. PMID: 16633861 Review.

8

XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Poulin Y, Bissonnette R, Juneau C, Cantin K, Drouin R, Poubelle PE. Poulin Y, et al. J Cutan Med Surg. 2006 Sep-Oct;10(5):241-8. doi: 10.2310/7750.2006.00049. J Cutan Med Surg. 2006. PMID: 17234108 Clinical Trial.

9

XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Poulin Y, Bissonnette R, Juneau C, Cantin K, Drouin R, Poubelle PE. Poulin Y, et al. Altern Med Rev. 2007 Dec;12(4):352-9. Altern Med Rev. 2007. PMID: 18069904 Clinical Trial.

10

Etanercept in the treatment of palmoplantar pustulosis.

Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S. Bissonnette R, et al. Among authors: poulin y, poulin costello cm. J Drugs Dermatol. 2008 Oct;7(10):940-6. J Drugs Dermatol. 2008. PMID: 19112757 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page